| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 02/17/2009 | US7491718 Aminopeptidase inhibitor; vision defects; administering to eye |
| 02/12/2009 | WO2009020470A2 Cgrp receptor antagonists |
| 02/12/2009 | WO2009019445A1 Dithiazolidine and thiazolidine derivatives as anticancer agents |
| 02/12/2009 | WO2009018657A1 Viral polymerase inhibitors |
| 02/12/2009 | US20090043096 Method of producing aromatic compound |
| 02/12/2009 | US20090043094 Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives |
| 02/12/2009 | US20090042929 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors |
| 02/12/2009 | US20090042926 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment |
| 02/12/2009 | US20090042885 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 02/12/2009 | US20090042872 Rhodanine Derivatives, a Process for the Preparation Thereof and Pharmaceutical Composition Containing the Same |
| 02/12/2009 | US20090042867 Compounds for the treatment of alzheimer's disease |
| 02/12/2009 | US20090041791 for linking drug moieties to ligands; comprises a peptide sequence that is a substrate for an intracellular enzyme, for example a cathepsin, that cleaves the peptide at an amide bond |
| 02/12/2009 | CA2693997A1 Viral polymerase inhibitors |
| 02/11/2009 | EP2022500A1 Tumor suppressor |
| 02/11/2009 | EP2021316A1 Inhibitors of polo-like kinases |
| 02/11/2009 | CN101365698A 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof |
| 02/11/2009 | CN101365681A Iminopropene compound and use thereof |
| 02/11/2009 | CN101362735A Preparation method of ethyl 2-[[(bezyloxy)carbonyl]amido]-4-thiazolyl acetate |
| 02/11/2009 | CN101362734A One-pot preparation method of chlorate 2-(2-aminothiazol-4-yl)-2-methoxyiminoacetate |
| 02/11/2009 | CN101362733A Method for preparing cefixime side chain active ester |
| 02/11/2009 | CN101362732A Method for preparing cefixime side chain compound |
| 02/10/2009 | CA2211270C Novel cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 02/05/2009 | WO2009018065A2 Novel glucokinase activators and methods of using same |
| 02/05/2009 | WO2009017822A2 Pi3 kinase modulators and methods of use |
| 02/05/2009 | WO2009017346A1 Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition for preventing or treating osteoporosis comprising the same |
| 02/05/2009 | WO2009017098A1 Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity and intermediate thereof |
| 02/05/2009 | WO2009016964A1 Light-emitting device material and light-emitting device |
| 02/05/2009 | WO2009016087A1 Monoamide derivatives as orexin receptor antagonists |
| 02/05/2009 | WO2009015877A1 Novel herbicides |
| 02/05/2009 | WO2008104847A3 Processes for the preparation of pramipexole and salts thereof |
| 02/05/2009 | US20090036493 Benzimidazole Derivatives and Their Use for Modulating the GABA Alpha Receptor Complex |
| 02/05/2009 | US20090036467 Alkylsulfonyl-substituted thiazolide compounds |
| 02/05/2009 | US20090036457 Utilities of olefin derivatives |
| 02/05/2009 | US20090036450 Pyrazole compounds and use thereof |
| 02/05/2009 | CA2694639A1 Benzamidine derivatives, process for the preparation thereof and pharmaceutical composition for preventing or treating osteoporosis comprising the same |
| 02/05/2009 | CA2694567A1 Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity and intermediate thereof |
| 02/05/2009 | CA2694276A1 Monoamide derivatives as orexin receptor antagonists |
| 02/05/2009 | CA2694136A1 Pi3 kinase modulators and methods of use |
| 02/05/2009 | CA2693190A1 Novel herbicides |
| 02/04/2009 | EP2019824A2 Benzamide glucokinase activators |
| 02/04/2009 | EP2019823A2 Benzamide glucokinase activators |
| 02/04/2009 | EP2019674A2 Histone deacetylase and tubulin deacetylase inhibitors |
| 02/04/2009 | EP1824817B1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 02/04/2009 | EP1565422B1 Vitamin d receptor modulators |
| 02/04/2009 | EP1492773B1 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation |
| 02/04/2009 | CN101360730A Fungicide N-cycloalkyl-benzyl-amide derivatives |
| 02/04/2009 | CN101360707A Thrombopoietin activity modulating compounds and methods |
| 02/04/2009 | CN101360706A (R)-arylalkylamino derivatives and pharmaceutical compositions containing them |
| 02/04/2009 | CN101357908A Bisbenzothiazole disulfide and triphenylphosphine preparation by means of one pot |
| 02/04/2009 | CN101357907A 2-aryl-substituted benzothiazolines compound and derivate thereof, preparation method and application |
| 02/04/2009 | CN100457753C N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
| 02/04/2009 | CN100457744C Process for preparing thiazole derivative and the intermediate compounds for preparing the same |
| 02/03/2009 | US7485655 2-Aminothiazole allosteric enhancers of A1 adenosine receptors |
| 02/03/2009 | CA2355359C Use of riluzole for treating acoustic traumas |
| 02/03/2009 | CA2299271C Prodrugs and conjugates of thiol- and selenol- containing compounds and methods of use thereof |
| 01/29/2009 | WO2009015369A2 Isophthalamide derivatives inhibiting beta-secretase activity |
| 01/29/2009 | WO2009015273A2 Testing of roaming transactions |
| 01/29/2009 | WO2009014674A1 Heterocyclylamides as gut microsomal triglyceride transport protein inhibitors |
| 01/29/2009 | WO2009014267A2 Imidate compound and use thereof for pest control |
| 01/29/2009 | WO2009012998A1 Novel microbiocides |
| 01/29/2009 | WO2009012958A2 Tubulysin d analogues |
| 01/29/2009 | WO2009012954A1 Novel estrogen receptor ligands |
| 01/29/2009 | WO2008063781A3 Chemical compounds as cannabinoid receptor ligands |
| 01/29/2009 | WO2007061661A4 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 01/29/2009 | US20090030210 Process for Producing Optically Active 2-Alkylcysteine, Derivative Thereof, and Processes for Production |
| 01/29/2009 | US20090030046 N-[3-[(2S)-1-methoxypropan-2-yl]oxy-5-(4-methylsulfonylphenoxy)phenyl]-1H-imidazole-5-carboxamide, used as antidiabetic agents, especially for the treatment of non-insulin dependent diabetes |
| 01/29/2009 | US20090030038 Novel 8-Sulfonylamino-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5Ht6 Receptor |
| 01/29/2009 | US20090030000 Antiviral agents |
| 01/29/2009 | US20090029998 Thiazole Derivatives and Use Thereof |
| 01/29/2009 | US20090029997 Thiazole Derivatives and Use Thereof |
| 01/29/2009 | US20090029995 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 01/29/2009 | US20090029991 Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/29/2009 | CA2697166A1 Isophthalamide derivatives inhibiting betasecretase activity |
| 01/28/2009 | EP2019095A1 Iminooxazole and iminothiazole compounds as pesticides |
| 01/28/2009 | EP2018367A1 Novel microbiocides |
| 01/28/2009 | EP1418910B1 Methods for inhibiting or reversing tau filament formation polymerization |
| 01/28/2009 | EP0966443B1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
| 01/28/2009 | CN101356161A Heterocyclic CETP inhibitors |
| 01/28/2009 | CN100455574C Thiazoline acid derivatives |
| 01/28/2009 | CN100455565C Sulfonamide anions as catalysts for nco oligomerization |
| 01/27/2009 | US7482466 Hydroxamates as therapeutic agents |
| 01/27/2009 | US7482462 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma |
| 01/27/2009 | US7482437 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 01/27/2009 | US7482370 Compounds for the treatment of inflammatory disorders |
| 01/27/2009 | US7482364 Histamine H3 antagonists; do not contain imidazolyl moiety; such as 1-[4-(4-piperidin-1-ylmethyl-phenyl)-but-3-ynyl]-piperidine |
| 01/27/2009 | US7482346 Carboxylation of the alkylpiperazine; amidation of the carbamate-ester; cannabinoid and vanilloid receptor antagonists |
| 01/27/2009 | CA2377126C Thiazole and oxazole derivatives and their pharmaceutical use |
| 01/27/2009 | CA2355243C Novel 2-(n-cyanoimino)thiazolidin-4-one derivatives |
| 01/27/2009 | CA2247443C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma |
| 01/22/2009 | WO2009010694A2 Dyeing method using a styryl- or imine-type disulfide/thiol compound and stimuli, composition and device for implementing same |
| 01/22/2009 | WO2009010454A2 Amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors |
| 01/22/2009 | US20090023929 Intermediate of 6-Substituted 1-Methyl-1-H-Benzimidazole Derivative and Method for Producing Same |
| 01/22/2009 | US20090023928 Phthalamide-lanthanide complexes for use as luminescent markers |
| 01/22/2009 | US20090023734 Treating cell proliferative disorders |
| 01/22/2009 | US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections |
| 01/22/2009 | US20090023718 Diamine and Iminodiacetic Acid Hydroxamic Acid Derivatives |
| 01/22/2009 | US20090023664 protease inhibitors such as 5-(dimethylamino)-N-[(2S,3R)-3-hydroxy-4-[(4-methoxyphenyl)sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-2-methylbenzamide, used for for treating human immunodeficiency virus (HIV) infections |
| 01/22/2009 | US20090023173 Luminescence-based methods and probes for measuring cytochrome P450 activity |
| 01/22/2009 | CA2694748A1 Sodium channel inhibitors |
| 01/21/2009 | EP2017269A2 A pharmaceutical compodition comprising form II crystalline Ritonavir and a preparation thereof |